Literature DB >> 1702541

Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts.

M J Adler1, C Coronel, E Shelton, J E Seegmiller, N N Dewji.   

Abstract

The pathological hallmark of Alzheimer disease is the accumulation of neurofibrillary tangles and neuritic plaques in the brains of patients. Plaque cores contain a 4- to 5-kDa amyloid beta-protein fragment which is also found in the cerebral blood vessels of affected individuals. Since amyloid deposition in the brain increases with age even in normal people, we sought to establish whether the disease state bears a direct relationship with normal aging processes. As a model for biological aging, the process of cellular senescence in vitro was used. mRNA levels of beta-amyloid precursor protein associated with Alzheimer disease were compared in human fibroblasts in culture at early passage and when the same fibroblasts were grown to senescence after more than 52 population doublings. A dramatic increase in mRNA was observed in senescent IMR-90 fibroblasts compared with early-passage cells. Hybridization of mRNA from senescent and early proliferating fibroblasts with oligonucleotide probes specific for the three alternatively spliced transcripts of the gene gave similar results, indicating an increase during senescence of all three forms. A similar, though more modest, increase in message levels was also observed in early-passage fibroblasts made quiescent by serum deprivation; with repletion of serum, however, the expression returned to previous low levels. ELISAs were performed on cell extracts from senescent, early proliferating, and quiescent fibroblasts, and quiescent fibroblasts repleted with serum for over 48 hr, using polyclonal antibodies to a synthetic peptide of the beta-amyloid precursor. The results confirmed that the differences in mRNA expression were partially reflected at the protein level. Regulated expression of beta-amyloid precursor protein may be an important determinant of growth and metabolic responses to serum and growth factors under physiological as well as pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702541      PMCID: PMC50738          DOI: 10.1073/pnas.88.1.16

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

2.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

3.  Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and age- and sex-matched controls.

Authors:  N R Sims; J P Blass
Journal:  Metab Brain Dis       Date:  1986-03       Impact factor: 3.584

4.  Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats.

Authors:  Y Uchida; Y Ihara; M Tomonaga
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

5.  Overexpression of amyloid precursor protein A4 (beta-amyloid) immunoreactivity in genetically transformed cells: implications for a cellular model of Alzheimer amyloidosis.

Authors:  C A Marotta; W G Chou; R E Majocha; R Watkins; C LaBonne; S B Zain
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease.

Authors:  N R Sims; J M Finegan; J P Blass
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

7.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

Authors:  D Goldgaber; M I Lerman; O W McBride; U Saffiotti; D C Gajdusek
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

8.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.

Authors:  S Bahmanyar; G A Higgins; D Goldgaber; D A Lewis; J H Morrison; M C Wilson; S K Shankar; D C Gajdusek
Journal:  Science       Date:  1987-07-03       Impact factor: 47.728

9.  Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate.

Authors:  D Schubert; M LaCorbiere; T Saitoh; G Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease.

Authors:  M Goedert
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  10 in total

1.  Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.

Authors:  S Kumar; A J Millis; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  USF binds to the APB alpha sequence in the promoter of the amyloid beta-protein precursor gene.

Authors:  A A Vostrov; W W Quitschke; F Vidal; A L Schwarzman; D Goldgaber
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

3.  Amyloid precursor protein (APP) mRNA level is higher in the old mouse cerebral cortex and is regulated by sex steroids.

Authors:  Thamil Mani Sivanandam; M K Thakur
Journal:  J Mol Neurosci       Date:  2010-06-19       Impact factor: 3.444

Review 4.  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Authors:  Kumar Sambamurti; Nigel H Greig; Debomoy K Lahiri
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

Authors:  B D Chang; K Watanabe; E V Broude; J Fang; J C Poole; T V Kalinichenko; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 6.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

Review 7.  Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans.

Authors:  Zinnat Hasina; Nicole Wang; Chi Chiu Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-23

8.  The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth.

Authors:  Q Zhan; K A Lord; I Alamo; M C Hollander; F Carrier; D Ron; K W Kohn; B Hoffman; D A Liebermann; A J Fornace
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

9.  Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer's Disease Pathology, Constitute a Potential Object for Early Diagnosis.

Authors:  Gustavo Lopez-Toledo; Maria-Del-Carmen Silva-Lucero; Jorge Herrera-Díaz; David-Erasmo García; José-Antonio Arias-Montaño; Maria-Del-Carmen Cardenas-Aguayo
Journal:  Front Aging Neurosci       Date:  2022-07-01       Impact factor: 5.702

10.  Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis.

Authors:  D W Rose; G McCabe; J R Feramisco; M Adler
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.